Fluctuation of annexin-A1 positive mast cells in chronic granulomatous inflammation

Inflammation Research

Volumn 57, Issue 10, 2008, Pages 450-456

  Oliani, S M ^a,b   Ciocca, G A Panin ^a   Pimentel, T A ^b   Damazo, A S ^a   Gibbs, L ^c   Perretti, M ^c  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Air pouch model; Granuloma; Lipocortin 1; Mast cell; Neutrophil; Skin

Indexed keywords

CROTON OIL; FREUND ADJUVANT; LIPOCORTIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; FEMALE; GRANULOMATOUS INFLAMMATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACROPHAGE; MAST CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SKIN GRANULOMA;

ANIMALS; ANNEXIN A1; CHRONIC DISEASE; CROTON OIL; DERMATOLOGIC AGENTS; FEMALE; GRANULOMA; INFLAMMATION; MAST CELLS; MICE; SKIN;

EID: 58149233871     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-008-7222-7     Document Type: Article

References (58)

1. Bischoff SC. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol 2007; 7: 93-104.
2. Marone G, Genovese A, Granata F, Forte V, Detoraki A, De Paulis A, Triggiani M. Pharmacological modulation of human mast cells and basophils. Clin Exp Allergy 2002; 32: 1682-9.
3. Carollo M, Hogaboam CM, Kunkel SL, Delaney S, Christie MI, Perretti M. Analysis of the temporal expression of chemokines and chemokine receptors during experimental granulomatous inflammation: role and expression of MIP-1alpha and MCP-1. Br J Pharmacol 2001; 134: 1166-79.
4. Walsh LJ. Mast cells and oral inflammation. Crit Rev Oral Biol Med 2003; 14: 188-98.
5. Galli SJ. New insights into "the riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 1990; 62: 5-33.
6. Abraham SN, Malaviy AR. Mast cells in infection and immunity. Infect Immun 1997; 65: 3501-8.
7. Galli SJ, Maurer M, Lantz CS. Mast cells as sentinels of innate immunity. Curr Opin Immunol 1999; 11: 53-9.
8. Williams CMM, Galli SJ. Mast cell can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med 2000; 192: 455-62.
9. Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 2003; 117: S450-6.
10. Metz M, Grimbaldeston MA, Nakae S, Piliponsky AM, Tsai M, Galli SJ. Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev 2007; 217: 304-28.
11. Au SR, Au K, Saggers GC, Karne N, Ehrlich HP. Rat mast cells communicate with fibroblasts via gap junction intercellular communications. J Cell Biochem 2007; 100: 1170-7.
12. Levi-Schaffer F. Mast cell/fibroblast interactions in health and disease. Chem Immunol 1995; 61: 161-85.
13. Bachelet I, Munitz A, Levi-Schaffer F. Co-culture of mast cells with fibroblasts: a tool to study their crosstalk. Methods Mol Biol 2006; 315: 295-317.
14. Yamamoto T, Hartmann K, Eckes B, Krieg T. Mast cells enhance contraction of three-dimensional collagen lattices by fibroblasts by cell-cell interaction: role of stem cell factor/c-kit. Immunology 2000; 99: 435-9.
15. Benoist C, Mathis D. Mast cells in autoimmune disease. Nature 2002; 420: 875-8.
16. Gibbs L, Carollo MG, Damazo AS, Oliani SM, Perretti M. Time-dependent expression of annexin 1 in a model of chronic granulomatous inflammation. Inflamm Res 2002; 51: 300-6.
17. Yamamoto T, Katayama I, Nishioka K. Role of mast cells in dermatofibroma: recent viewpoints into the pathogenesis. Eur J Dermatol 2003; 13: 419-23.
18. Haynes DC, Gershwin ME. The immunopathology of progressive systemic sclerosis (PSS). Semin Arthritis Rheum 1982;11: 331-51.
19. Schmidt-Weber CB, Blaser K. The role of TGF-b in allergic inflammation. Immunol Allergy Clin North Am 2006;26:233-44, vi-vii.
20. Steinke JW, Negri J, Enelow R, Baramki DF, Borish L. Proinflammatory effects of IL-4 antagonism. J Allergy Clin Immunol 2006;118:756-58.
21. Akdis CA, Blaser K. Mechanisms of interleukin-10-mediated immune suppression. Immunology 2001;103: 131-6.
22. Hart PH, Grimbaldeston MA, Finlay-Jones JJ. Sunlight, immunosuppression and skin cancer: role of histamine and mast cells. Clin Exp Pharmacol Physiol 2001;28:1-8.
23. Silistino-Souza R, Rodrigues-Lisoni FC, Cury PM, Maniglia JV, Raposo LS, Tajara EH, Christian HC, Oliani SM. Annexin 1: differential expression in tumor and mast cells in human larynx cancer. Int J Cancer 2007; 120: 2582-9.
24. Oliani SM, Christian HC, Manston J, Flower RJ, Perretti M. An immunocytochemical and in situ hybridization analysis of annexin 1 expression in rat mast cells: modulation by inflammation and dexamethasone. Lab Invest 2000; 80: 1429-38.
25. Damazo AS, Straus AH, Paul-Clarck MJ, Takahashi HW, Perretti M, Oliani SM. Analysis of the annexin 1 expression in rat trachea: study of mast cell heterogeneity. Annexins 2004; 1: 12-8.
26. Gerke V, Creutz CE, Moss SE. Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 2005; 6: 449-61.
27. Damazo AS, Yona S, Flower RJ, Perretti M, Oliani SM. Spatial and temporal profiles for anti-inflammatory gene expression in leukocytes during a resolving model of peritonitis. J Immunol 2006; 176: 4410-8.
28. Buckingham JC. Fifteenth Gaddum Memorial Lecture December 1994. Stress and the neuroendocrine-immune axis: the pivotal role of glucocorticoids and lipocortin 1. Br J Pharmacol 1996; 118: 1-19.
29. Sena AA, Provazzi PJ, Fernandes AM, Cury PM, Rahal P, Oliani SM. Spatial expression of two anti-inflammatory mediators, annexin 1 and galectin-1, in nasal polyposis. Clin Exp Allergy 2006; 36: 1260-7.
30. Eklund KK. Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapy. Immunol Rev 2007; 217: 38-52.
31. Nigrovic PA, Lee DM. Synovial mast cells: role in acute and chronic arthritis. Immunol Rev 2007; 217: 19-37.
32. Kimura M, Suzuki J, Amemiya K. Mouse granuloma pouch induced by Freund's complete adjuvant with croton oil. J Pharmacobiodyn 1985; 8: 393-400.
33. Appleton I, Brown NJ, Willis D, Colville-Nash PR, Alam L, Brown JR, Willoughby DA. The role of vascular endothelial growth factor in a murine chronic granulomatous tissue air-pouch model of angiogenesis. J Pathol 1996; 180: 90-4.
34. Junqueira LCU, Bignolas G, Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 1979; 11: 447-55.
35. Von Stebut E, Metz M, Milon G, Knop J, Maurer M. Early macrophage influx to sites of cutaneous granuloma formation is dependent on MIP-1alpha /beta released from neutrophils recruited by mast cell-derived TNFalpha. Blood 2003; 101: 210-5.
36. Pawankar R, Lee KH, Nonaka M, Takizawa R. Role of mast cells and basophils in chronic rhinosinusitis. Clin Allergy Immunol 2007; 20: 93-101.
37. Appleton I, Tomlinson A, Colville-Nash PR, Willoughby DA. Temporal and spatial immunolocalization of cytokines in murine chronic granulomatous tissue. Implications for their role in tissue development and repair processes. Lab Invest 1993; 69: 405-14.
38. Russo A, Russo G, Peticca M, Pietropaolo C, Di Rosa M, Iuvone T. Inhibition of granuloma-associated angiogenesis by controlling mast cell mediator release: role of mast cell protease-5. Br J Pharmacol 2005; 145: 24-33.
39. Galli SJ. The Paul Kallos Memorial Lecture. The mast cell: a versatile effector cell for a challenging world. Int Arch Allergy Immunol 1997; 113: 14-22.
40. Williams CMM, Galli SJ. Diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol 2000; 105: 847-59.
41. Boyce JA. Mast cells: beyond IgE. J Allergy Clin Immunol, v. 111, n. 1, p. 24-32, 2003.
42. Hiromatsu Y, Toda S. Mast cells and angiogenesis. Microsc Res Tech 2003; 60: 64-9.
43. Maurer M, Theoharides T, Granstein RD, Bischoff SC, Bienenstock J, Henz B, Kovanen P, Piliponsky AM, Kambe N, Vliagoftis H, Levi-Schaffer F, Metz M, Miyachi Y, Befus D, Forsythe P, Kitamura Y, Galli S. What is the physiological function of mast cells? Exp Dermatol 2003; 12: 886-910.
44. Pejler G, Abrink M, Ringvall M, Wernersson S. Mast cell proteases. Adv Immunol 2007; 95: 167-255.
45. Andoh A, Deguchi Y, Inatomi O, Yagi Y, Bamba S, Tsujikawa T, Fujiyama Y. Immunohistochemical study of chymase-positive mast cells in inflammatory bowel disease. Oncol Rep 2006; 16: 103-7.
46. Algermissen B, Hermes B, Feldmann-Boeddeker I, Bauer F, Henz BM. Mast cell chymase and tryptase during tissue turnover: analysis on in vitro mitogenesis of fibroblasts and keratinocytes and alterations in cutaneous scars. Exp Dermatol 1999; 8: 193-8.
47. Lees M, Taylor DJ, Woolley DE. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B. Eur J Biochem 1994; 223: 171-7.
48. Cairns JA, Walls AF. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest 1997; 99: 1313-21.
49. Artuc M, Steckelings UM, Henz BM. Mast cell-fibroblast interactions: human mast cells as source and inducers of fibroblast and epithelial growth factors. J Invest Dermatol 2002; 118: 391-5.
50. Fukushima H, Ohsawa M, Ikura Y, Naruko T, Sugama Y, Suekane T, Kitabayashi C, Inoue T, Hino M, Ueda M. Mast cells in diffuse large B-cell lymphoma; their role in fibrosis. Histopathology 2006; 49: 498-505.
51. Tataroglu C, Sarioglu S, Kargi A, Ozkal S, Aydin O. Fibrosis in Hodgkin and non-Hodgkin lymphomas. Pathol Res Pract 2007; 203: 725-30.
52. Flower RJ, Blackwell GJ. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature 1979; 278: 456-9.
53. Lim LH, Pervaiz S. Annexin 1: the new face of an old molecule. FASEB J 2007; 21: 968-75.
54. Perretti M, Flower RJ. Annexin 1 and the biology of the neutrophil. J Leukoc Biol 2004; 76: 25-9.
55. Perretti M, Croxtall J.D, Wheller S.K, Goulding N.J, Hannon R, Flower R.J. Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nat Med 1996; 2: 1259-62.
56. Chatterjee BE, Yona S, Rosignoli G, Young RE, Nourshargh S, Flower RJ, Perretti M. Annexin 1-deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro. J Leukoc Biol 2005; 78: 639-46.
57. Canaider S, Solito E, De Coupade C, Flower RJ, Russo-Marie F, Goulding NJ, Perretti M. Increased apoptosis in U937 cells overexpressing lipocortin 1 (annexin 1). Life Sci 2000; 66: 265-70.
58. Solito E, Kamal A, Russo-Marie F, Buckingham JC, Marullo S, Perretti M. A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophil. FASEB J 2003; 17: 1544-6.